Other Stories

S. Korean quarantine authorities to discuss emergency approval on Remdesivir imports Updated: 2020-05-28 14:21:27 KST

South Korea's quarantine authorities are set to review possible emergency approval on imports of (rem-dessy-veer) Remdesivir, an Ebola treatment that has emerged as a new hope in tackling COVID-19.
A group of infectious disease experts held related discussions on Thursday.
A senior official from the Korea Centers for Disease Control and Prevention said during a press briefing this week that depending on the outcomes of the experts' meeting, necessary procedures will be dealt with by the Ministry of Food and Drug Safety.
According to the U.S. National Institutes of Health, Remdesivir has successfully shortened the median recovery time from fifteen days to eleven.
KOGL : Korea Open Government License
본 저작물 중 본문에 해당하는 뉴스 스크립트(텍스트)는 공공누리 제1유형-출처표시 조건에 따라 이용할 수 있습니다.